Martin, L-A;
Ribas, R;
Simigdala, N;
Schuster, E;
Pancholi, S;
Tenev, T;
Gellert, P;
... Dowsett, M; + view all
(2017)
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.
Nature Communications
, 8
, Article 1865. 10.1038/s41467-017-01864-y.
Preview |
Text
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.pdf - Published Version Download (2MB) | Preview |
Abstract
Resistance to endocrine therapy remains a major clinical problem in breast cancer. Genetic studies highlight the potential role of estrogen receptor-α (ESR1) mutations, which show increased prevalence in the metastatic, endocrine-resistant setting. No naturally occurring ESR1 mutations have been reported in in vitro models of BC either before or after the acquisition of endocrine resistance making functional consequences difficult to study. We report the first discovery of naturally occurring ESR1 Y537C and ESR1 Y537S mutations in MCF7 and SUM44 ESR1-positive cell lines after acquisition of resistance to long-term-estrogen-deprivation (LTED) and subsequent resistance to fulvestrant (ICIR). Mutations were enriched with time, impacted on ESR1 binding to the genome and altered the ESR1 interactome. The results highlight the importance and functional consequence of these mutations and provide an important resource for studying endocrine resistance.
| Type: | Article |
|---|---|
| Title: | Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41467-017-01864-y |
| Publisher version: | https://doi.org/10.1038/s41467-017-01864-y |
| Language: | English |
| Additional information: | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10068489 |
Archive Staff Only
 |
View Item |
